Stock Comparison
ARGX vs RPRX
argenx NV ADR and Royalty Pharma Plc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$32.38B
P/E (TTM)
39.4
29.6
Forward P/E
34.0
46.5
Price/Sales
11.7
13.3
Price/Book
7.5
3.6
EV/EBITDA
33.9
19.1
Dividend Yield
—
1.64%
Profitability
Net Margin
31.40%
33.90%
Operating Margin
30.00%
100.30%
Return on Equity
20.20%
13.80%
Return on Assets
8.86%
5.54%
Growth (YoY)
Revenue Growth
62.60%
11.00%
Earnings Growth
114.00%
23.20%
Price & Risk
Beta
-0.0
0.4
52-Week High
$934.62
$56.50
52-Week Low
$510.06
$33.57
Analyst Target
$1,041.14
$59.25
Compare ARGX and RPRX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.